Nurse Practitioner · Kansas City, KS
NPI
1497112304
Since 2016
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3901 Rainbow Blvd
Kansas City, KS, 66160
Phone (913) 588-9365
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
681 services
Medicare patients, 2024
161
Average age 68
Drug cost, 2024
$2.2M
488 prescriptions
Company payments, 2025
$861
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sepideh Nikbakht was code 99215 (office e&m - established), 347 times for 122 patients. In total Sepideh Nikbakht billed 681 services in 10 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 347 | 122 | $92.14 | $32K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 256 | 100 | $10.85 | $2,778 |
| 38222 Other Organ Systems | Office | 45 | 42 | $45.45 | $2,045 |
| 99214 Office E&M - Established | Office | 20 | 20 | $63.55 | $1,271 |
By year: 2022 $15K for 261 services; 2023 $19K for 330 services; 2024 $39K for 681 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sepideh Nikbakht prescribed most often to Medicare patients was Rezurock (Belumosudil Mesylate), with 50 prescriptions and refills. In total Sepideh Nikbakht wrote 488 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rezurock Belumosudil Mesylate | 50 | 50 | Under 11 | $1.4M |
| Jakafi Ruxolitinib Phosphate | 49 | 49 | 12 | $604K |
| Acyclovir Generic | 45 | 61 | 19 | $578 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 34 | 40 | 15 | $96.88 |
| Oxycodone Hcl Generic | 24 | 24 | 13 | $142 |
| Levothyroxine Sodium Generic | 16 | 42 | Under 11 | $110 |
| Gabapentin Generic | 15 | 26 | Under 11 | $202 |
| Levofloxacin Generic | 12 | 14 | Under 11 | $69.75 |
Brand drugs: 147 claims; generic drugs: 341 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sepideh Nikbakht $861 ($861 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $186.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 3 | $186 |
| Amgen Inc. AMGN | 1 | $130 |
| Astellas Pharma US Inc 4503.T | 1 | $127 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $126 |
| Axsome Therapeutics, Inc. AXSM | 1 | $120 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $107 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $25.95 |
| Syndax Pharmaceuticals, Inc. SNDX | 1 | $20.21 |
| Taiho Oncology, Inc. 4578.T | 1 | $19.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.